衛報: 拒絕上海復星的BNT疫苗全是政治考量
《衛報》與《泰晤士報》、《每日電訊報》同為英國三個著名的高級報紙。
==================================================================
英文很爛，只翻重點
(1)前美國國防部負責中台雙邊關係的官員湯普森說:
中國表示持有輝瑞BNT疫苗獨家地區代理權的上海復星醫藥願提供疫苗給台灣，卻被拒絕。
但因為中國疫苗在科學上及透明度都有疑慮，所以台灣若拒絕接受中國自己研發的疫苗
非常明智也不意外。
可是如果復星醫藥提供的是BNT合格商品，台灣拒絕就完全只是政治考量。
因為輝瑞跟BNT為了巨大利益，必須確保復星的產品是同級品。
所以我不認為這樣的疫苗會有疑慮，也沒有拒絕的理由。
(2)他又說: 對民進黨而言，若接受中國疫苗就像政治上的死亡之吻，
等同投降或承認北京的霸權。
(3)一位在台大的外籍學者也說: 民進黨為了選舉利益，就是不願拿中國的疫苗。
重點原文:
(1)China said Fosun – the Shanghai-based manufacturer with exclusive regional
production rights for Pfizer/BioNTech – had offered to supply Taiwan, but
Taiwan had refused.
Thompson said there were scientific and transparency concerns about China's
vaccines, which made it unsurprising and potentially sensible for Taiwan to
reject an offer of Chinese-developed vaccines.
But if the Fosun offer is legitimate, refusing it is "entirely political".
Pfizer and BioNTech have a huge incentive to ensure that the Fosun product is
equivalent, so I would think there is no concern,” he said
“There's no reason not to take it.”
(2)If Taiwan accepted Chinese vaccines it would be the political
“kiss of death for the DPP [Taiwan's ruling party]”, Thompson said.
(3)But Lev Nachman, a visiting scholar at the National Taiwan University, said
it still seemed “in the DPP's electoral interest not to get any China
vaccines”
https://tinyurl.com/hyph3s3u